Phase II Study of the Addition of Bevacizumab to Standard Chemoradiation for Loco-regionally Advanced Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group (RTOG) Trial 0615

PURPOSE: We sought to improve the outcomes for loco-regionally advanced nasopharyngeal carcinoma (NPC) by testing the feasibility/safety of adding bevacizumab to chemoradiation. PATIENTS/METHODS: Eligible patients with ≥T2b and/or positive node(s) were prescribed 3 cycles of bevacizumab (15 mg/kg) a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Oncol
Main Authors: Lee, Nancy Y., Zhang, Ed, Pfister, David. G., Kim, John, Garden, Adam. S., Mechalakos, James, Hu, Kenneth, Le, Quynh T., Colevas, A. Dimitrios, Glisson, Bonnie S., Chan, Anthony T.C., Ang, K. Kian
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4985181/
https://ncbi.nlm.nih.gov/pubmed/22178121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(11)70303-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados